Community Health Systems Inc (CYH) stock
Close on Nov 17, 2026Market cap $284.87MP/E 7.8Yield –
Earnings
Community Health Systems's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Community Health Systems's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 17, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 28, 2026after the close | $2.76B | -10.7% | -$0.63 | -$0.48 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 22, 2026during market hours | $2.83B | -9.8% | $0.51 | -$0.19 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 21, 2026during market hours | $2.97B | -6.1% | -$0.43 | -$0.48 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 18, 2026during market hours | $3.11B | -4.9% | $0.81 | $0.00 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 23, 2025during market hours | $3.09B | -0.1% | $0.96 | $1.27 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 23, 2025during market hours | $3.13B | -0.2% | $2.09 | -$0.05 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 23, 2025during market hours | $3.16B | +0.6% | -$0.10 | -$0.03 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 18, 2025during market hours | $3.27B | +2.6% | -$0.53 | -$0.42 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 23, 2024during market hours | $3.09B | +0.1% | -$2.95 | -$0.30 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 24, 2024during market hours | $3.14B | +0.8% | -$0.10 | -$0.17 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 24, 2024during market hours | $3.14B | +1.0% | -$0.32 | -$0.14 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 20, 2024during market hours | $3.18B | +1.2% | $0.35 | -$0.41 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 25, 2023during market hours | $3.09B | +2.0% | -$0.69 | -$0.33 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 2, 2023during market hours | $3.12B | +6.2% | -$0.29 | -$0.22 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 1, 2023during market hours | $3.11B | -0.1% | -$0.40 | -$0.43 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 15, 2023during market hours | $3.14B | – | $3.18 | $1.50 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 27, 2022during market hours | $3.03B | -2.9% | -$0.32 | -$0.52 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 27, 2022during market hours | $2.93B | – | -$2.52 | -$2.52 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 27, 2022during market hours | $3.11B | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Jan 18, 2022before the open | – | – | – | – | Filing |
| Q3 FY2021ended Sep 30, 2021 | Oct 27, 2021during market hours | $3.12B | – | $0.85 | $0.69 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 28, 2021during market hours | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 28, 2021during market hours | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 14, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 27, 2020during market hours | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Community Health Systems's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net operating revenuesGAAP | FY2026 | $11.30B – $11.50B | – | New | Oct 28, 2026 |
| Net operating revenues | FY2026 | $11.40B – $11.60B | – | New | Jul 22, 2026 |
| Net operating revenuesGAAP | FY2026 | $11.60B – $12.00B | – | New | Feb 18, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $1.23B – $1.28B | – | New | Oct 28, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $1.30B – $1.38B | $1.34B – $1.49B | Lowered | Jul 22, 2026 |
| Net loss per share - dilutedGAAP | FY2026 | -$1.70 – -$1.60 | – | New | Oct 28, 2026 |
| Net loss per share - dilutedGAAP | FY2026 | -$1.25 – -$1.10 | -$0.60 – $0.00 | Lowered | Jul 22, 2026 |
| Capital expenditures | FY2026 | $350.00M – $400.00M | – | New | Oct 28, 2026 |
| Capital expenditures | FY2026 | $350.00M – $400.00M | – | New | Jul 22, 2026 |
| Net cash provided by operating activitiesGAAP | FY2026 | $100.00M – $300.00M | – | New | Oct 28, 2026 |
| Net loss attributable to Community Health Systems, Inc. stockholdersGAAP | FY2026 | -$170.00M – -$149.00M | – | New | Jul 22, 2026 |
Guidance vs results
The last range Community Health Systems gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | EPS (GAAP) | $0.80 – $0.90 | $3.76Σ4Q | Above range |
| FY2025 | Revenue | $12.40B – $12.60B | $12.49BΣ4Q | Within range |
Guidance history
Every forecast Community Health Systems put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 28, 2026 | Capital expenditures | FY2026 | $350.00M – $400.00M | New |
| Oct 28, 2026 | Adjusted EBITDA | FY2026 | $1.23B – $1.28B | New |
| Oct 28, 2026 | Net loss per share - diluted | FY2026 | -$1.70 – -$1.60 | New |
| Oct 28, 2026 | Net cash provided by operating activities | FY2026 | $100.00M – $300.00M | New |
| Oct 28, 2026 | Net operating revenues | FY2026 | $11.30B – $11.50B | New |
| Jul 22, 2026 | Capital expenditures | FY2026 | $350.00M – $400.00M | New |
| Jul 22, 2026 | Adjusted EBITDA | FY2026 | $1.30B – $1.38B | Lowered |
| Jul 22, 2026 | Net loss per share - diluted | FY2026 | -$1.25 – -$1.10 | Lowered |
| Jul 22, 2026 | Net loss attributable to Community Health Systems, Inc. stockholders | FY2026 | -$170.00M – -$149.00M | New |
| Jul 22, 2026 | Net operating revenues | FY2026 | $11.40B – $11.60B | New |
| Feb 18, 2026 | Adjusted EBITDA | FY2026 | $1.34B – $1.49B | New |
| Feb 18, 2026 | Net loss per share - diluted | FY2026 | -$0.60 – $0.00 | New |
| Feb 18, 2026 | Net operating revenues | FY2026 | $11.60B – $12.00B | New |
| Oct 23, 2025 | Capital expenditures | FY2025 | $350.00M – $400.00M | New |
| Oct 23, 2025 | Adjusted EBITDA | FY2025 | $1.50B – $1.55B | New |
| Oct 23, 2025 | Net income per share - diluted | FY2025 | $0.80 – $0.90 | New |
| Oct 23, 2025 | Net cash provided by operating activities | FY2025 | $600.00M – $700.00M | New |
| Oct 23, 2025 | Net operating revenues | FY2025 | $12.40B – $12.60B | New |
| Jul 23, 2025 | Capital expenditures | FY2025 | $350.00M – $400.00M | Reaffirmed |
| Jul 23, 2025 | Adjusted EBITDA (in millions) | FY2025 | $1.45B – $1.55B | Lowered |
| Jul 23, 2025 | Net loss per share - diluted | FY2025 | -$0.40 – -$0.10 | Narrowed |
| Jul 23, 2025 | Weighted-average diluted shares (in millions) | FY2025 | 134 | New |
| Jul 23, 2025 | Net cash provided by operating activities | FY2025 | $600.00M – $700.00M | New |
| Jul 23, 2025 | Net operating revenues (in millions) | FY2025 | $12.30B – $12.60B | Raised |
| Feb 18, 2025 | Capital expenditures | FY2025 | $350.00M – $400.00M | New |
| Feb 18, 2025 | Adjusted EBITDA | FY2025 | $1.45B – $1.60B | New |
| Feb 18, 2025 | Net loss per share - diluted | FY2025 | -$0.55 – $0.00 | New |
| Feb 18, 2025 | Net cash provided by operating activities | FY2025 | $600.00M – $700.00M | New |
| Feb 18, 2025 | Net operating revenues | FY2025 | $12.20B – $12.60B | New |
| Oct 23, 2024 | Capital expenditures | FY2024 | $350.00M – $400.00M | Reaffirmed |
| Oct 23, 2024 | Adjusted EBITDA (in millions) | FY2024 | $1.50B – $1.54B | Lowered |
| Oct 23, 2024 | Net loss per share - diluted | FY2024 | -$0.60 – -$0.50 | Lowered |
| Oct 23, 2024 | Weighted-average diluted shares (in millions) | FY2024 | 132 – 133 | New |
| Oct 23, 2024 | Diluted weighted-average shares outstanding | FY2024 | 132 – 133 | Reaffirmed |
| Oct 23, 2024 | depreciation and amortization of approximately | FY2024 | 3.7% – 3.8% | New |
| Oct 23, 2024 | Total fixed rate debt | FY2024 | 97% | Raised |
| Oct 23, 2024 | net income attributable to noncontrolling interests | FY2024 | 1.2% – 1.3% | Lowered |
| Oct 23, 2024 | provision for income taxes | FY2024 | 0.8% – 0.9% | Lowered |
| Oct 23, 2024 | Interest expense | FY2024 | $850.00M – $860.00M | New |
| Oct 23, 2024 | cash paid for interest | FY2024 | $730.00M – $740.00M | Lowered |
| Oct 23, 2024 | Depreciation and amortization | FY2024 | $465.00M – $480.00M | Lowered |
| Oct 23, 2024 | Interest expense, net | FY2024 | $850.00M – $860.00M | Raised |
| Oct 23, 2024 | Provision for income taxes | FY2024 | $104.00M – $116.00M | Lowered |
| Oct 23, 2024 | Net income attributable to noncontrolling interests | FY2024 | $150.00M – $160.00M | Raised |
| Oct 23, 2024 | Net cash provided by operating activities | FY2024 | $400.00M – $500.00M | Raised |
| Oct 23, 2024 | estimated cash payments for income taxes | FY2024 | $150.00M – $200.00M | Lowered |
| Oct 23, 2024 | Net loss attributable to Community Health Systems, Inc. stockholders | FY2024 | -$79.00M – -$66.00M | Lowered |
| Oct 23, 2024 | Net operating revenues (in millions) | FY2024 | $12.45B – $12.55B | Narrowed |
| Jul 24, 2024 | Capital expenditures | FY2024 | $350.00M – $400.00M | New |
| Jul 24, 2024 | Adjusted EBITDA | FY2024 | $1.52B – $1.60B | Narrowed |
| Jul 24, 2024 | Net loss per share - diluted | FY2024 | -$0.45 – -$0.30 | Narrowed |
| Jul 24, 2024 | Net cash provided by operating activities | FY2024 | $500.00M – $650.00M | New |
| Jul 24, 2024 | Net operating revenues | FY2024 | $12.50B – $12.70B | New |
| Feb 20, 2024 | Capital expenditures | FY2024 | $350.00M – $400.00M | New |
| Feb 20, 2024 | Adjusted EBITDA | FY2024 | $1.48B – $1.63B | New |
| Feb 20, 2024 | Net loss per share - diluted | FY2024 | -$0.65 – -$0.05 | New |
| Feb 20, 2024 | Net operating revenues | FY2024 | $12.30B – $12.70B | New |
| Oct 25, 2023 | Capital expenditures | FY2023 | $450.00M – $500.00M | Reaffirmed |
| Oct 25, 2023 | Adjusted EBITDA | FY2023 | $1.45B – $1.50B | Lowered |
| Oct 25, 2023 | Net loss per share - diluted | FY2023 | -$1.00 – -$0.90 | Lowered |
| Oct 25, 2023 | Diluted weighted-average shares outstanding | FY2023 | 130 – 131 | Reaffirmed |
| Oct 25, 2023 | Net cash provided by operating activities | FY2023 | $400.00M – $450.00M | Lowered |
| Oct 25, 2023 | Net operating revenues | FY2023 | $12.40B – $12.50B | Narrowed |
| Feb 15, 2023 | Capital expenditures | FY2023 | $450.00M – $500.00M | New |
| Feb 15, 2023 | Adjusted EBITDA | FY2023 | $1.48B – $1.63B | New |
| Feb 15, 2023 | Net loss per share—diluted | FY2023 | -$0.65 – -$0.05 | New |
| Feb 15, 2023 | Diluted weighted-average shares outstanding | FY2023 | 130 – 131 | New |
| Feb 15, 2023 | depreciation and amortization | FY2023 | 4.2% | New |
| Feb 15, 2023 | Interest expense | FY2023 | $815.00M – $835.00M | New |
| Feb 15, 2023 | Net cash provided by operating activities | FY2023 | $675.00M – $825.00M | New |
| Feb 15, 2023 | Net operating revenues | FY2023 | $12.20B – $12.60B | New |
| Jul 27, 2022 | Capital expenditures | FY2022 | $400.00M – $450.00M | New |
| Jul 27, 2022 | Adjusted EBITDA | FY2022 | $1.30B – $1.40B | New |
| Jul 27, 2022 | Net loss per share - diluted | FY2022 | -$2.55 – -$1.65 | New |
| Jul 27, 2022 | Net operating revenues | FY2022 | $12.20B – $12.50B | New |
| Oct 27, 2021 | Capital expenditures | FY2021 | $450.00M – $500.00M | New |
| Oct 27, 2021 | Adjusted EBITDA | FY2021 | $1.78B – $1.82B | New |
| Oct 27, 2021 | Net income per share - diluted | FY2021 | $1.00 – $1.20 | New |
| Oct 27, 2021 | Net operating revenues | FY2021 | $12.15B – $12.35B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Community Health Systems filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Results
- Results
- News
- News
- News
- News
- Results
- News
- News
- News
- Results
- News
- News
- News
See a number that looks wrong?